Executive Summary
Samsung Austin Semiconductor challenges the '802 Patent covering Chemical Mechanical Planarization (CMP) pad dressing technology. The Petitioner argues that prior art references, including Tsai et al., anticipate or render obvious all 21 claimed claims. This is a foundational challenge to the patent's validity in semiconductor manufacturing.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Samsung Austin Semiconductor, LLC et al. vs Sung, Chien-Min is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Google LLCvsProxense, LLC
Google challenges Proxense's RFID authentication patents (8646042) in a Petition, arguing the claims are obvious over prior art. The petitioner asserts that existing technology discloses core elements of hybrid devices and proximity token systems. This proceeding is part of ongoing litigation between the parties.
Askeladden L.L.C.vsCalabrese Stemer LLC
The PTAB issued a Final Written Decision finding all nine claims unpatentable by anticipation (102) over the prior art reference Horie. The Board adopted a broad construction of 'distinct,' allowing for channel overlap, which supported the Petitioner's argument that the reference disclosed every element of the claims.
Samsung Electronics Co., Ltd. et al.vsIntent IQ, LLC
The PTAB issued a final decision rejecting the petitioner's challenge to claims 1-23 of U.S. Patent No. 10715878. The Board found that the evidence failed to demonstrate unpatentability under 35 U.S.C. § 103, upholding the patent owner’s rights regarding targeted advertising methods.
Micron Technology, Inc. et al.vsNetlist, Inc.
Micron Technology filed a Petition challenging 10268608's claims on grounds of obviousness (103). The petition asserts that the claimed memory module features are anticipated by combinations of prior art, including Hiraishi, Butt, Tokuhiro, Ellsberry, and Kim.
Merck Sharp & Dohme LLC et al.vsThe Johns Hopkins University
Merck Sharp & Dohme LLC successfully petitioned to institute IPR proceedings against The Johns Hopkins University regarding anti-cancer immunotherapy claims. The Board found sufficient evidence that the MSI-H Study Record anticipates key claims, warranting further trial on grounds of anticipation and obviousness.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.